TMCnet News
Nabi Biopharma Increases Buyback Program to $60.9 Million (NABI,GSK)Mar 23, 2010 (SmarTrend News Watch via COMTEX) -- 3/23/2010-The board of directors of Nabi Biopharmaceuticals (NASDAQ:NABI) added $50 million to the company's stock buyback program, raising the figure to $60.9 million, or nearly 20% of its market value, Dow Jones reported Tuesday. The board hasn't ruled out further expansion of the effort as the company gets "further clarity" on things such as potential milestone payments. Nabi generated its first revenue and profit in the fourth quarter due to the sale of a vaccine to GlaxoSmithKline (NYSE:GSK). Write to Chip Brian at [email protected] --------------------------------------------------------------------------------------------- SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.TradeTheTrend.com Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.TradeTheTrend.com/signup |